These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 19178934

  • 1. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
    Yang XY, Xi MR, Yang KX, Yu H.
    Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
    Liu S, Chia SK, Mehl E, Leung S, Rajput A, Cheang MC, Nielsen TO.
    Breast Cancer Res Treat; 2010 Jan; 119(1):53-61. PubMed ID: 19205877
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 5. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
    Liu JF, Hirsch MS, Lee H, Matulonis UA.
    Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
    [Abstract] [Full Text] [Related]

  • 6. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer.
    Lee P, Rosen DG, Zhu C, Silva EG, Liu J.
    Gynecol Oncol; 2005 Mar; 96(3):671-7. PubMed ID: 15721410
    [Abstract] [Full Text] [Related]

  • 7. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D, Susini T, Savino L, Boddi V, Amunni G, Colafranceschi M.
    Cancer; 1996 Mar 15; 77(6):1131-6. PubMed ID: 8635134
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL, Shajahan S, Khattar NH, Wilder DM, Yin J, Rushing RS, Beaven R, Kaetzel C, Ueland FR, van Nagell JR, Kryscio RJ, Lele SM.
    Gynecol Oncol; 2004 Feb 15; 92(2):553-8. PubMed ID: 14766247
    [Abstract] [Full Text] [Related]

  • 9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 15; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 11. Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers.
    Buchynska LG, Iurchenko NP, Grinkevych VM, Nesina IP, Chekhun SV, Svintsitsky VS.
    Exp Oncol; 2009 Mar 15; 31(1):48-51. PubMed ID: 19300417
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S, Schröder W, Steinhagen G, Koch R, Veuskens U, Schmitz FJ, Handt S, Böcking A.
    Anticancer Res; 1997 Mar 15; 17(6D):4723-9. PubMed ID: 9494596
    [Abstract] [Full Text] [Related]

  • 13. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.
    Croat Med J; 2003 Aug 15; 44(4):429-34. PubMed ID: 12950146
    [Abstract] [Full Text] [Related]

  • 14. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA, Topuz S, Tuzlali S, Bengisu E, Berkman S.
    Gynecol Oncol; 2005 Oct 15; 99(1):36-42. PubMed ID: 15992918
    [Abstract] [Full Text] [Related]

  • 15. [Expression of heat shock protein-70, estrogen receptor and progesterone receptor in ovarian carcinomas and the correlation between HSP70 and sex steroid receptor].
    Xing Y, Tang Z, Liao Y, Zhu SF, Li ZM, Chen ML.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul 15; 35(4):486-8. PubMed ID: 15291106
    [Abstract] [Full Text] [Related]

  • 16. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
    Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM.
    Int J Gynecol Pathol; 2007 Oct 15; 26(4):404-9. PubMed ID: 17885490
    [Abstract] [Full Text] [Related]

  • 17. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V, Briët J, de Jong R, ten Hoor K, Boezen M, van der Zee A, Nijman H, Hollema H.
    Gynecol Oncol; 2009 Mar 15; 112(3):537-42. PubMed ID: 19108875
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H.
    Gynecol Oncol; 1998 Jun 15; 69(3):220-5. PubMed ID: 9648591
    [Abstract] [Full Text] [Related]

  • 19. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P, Bäckström T, Mählck CG, Ridderheim M, Cajander S.
    Int J Oncol; 2001 Jul 15; 19(1):31-8. PubMed ID: 11408919
    [Abstract] [Full Text] [Related]

  • 20. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Gayther S, Jacobs IJ, Høgdall CK.
    Gynecol Oncol; 2007 Aug 15; 106(2):318-24. PubMed ID: 17540436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.